Navigation Links
HealthAware Introduces Its VascularAware Cardiovascular Disease Module
Date:2/20/2008

DENVER, Feb. 20 /PRNewswire/ -- HealthAware, a leading supplier of innovative services to healthcare providers, announced today the launch of VascularAware, the newest disease module in its Cardiovascular Program. VascularAware is designed to help people who may be at risk for Peripheral Artery Disease (PAD), which affects nearly 10 million adult Americans, according to the American Heart Association.

Development of the VascularAware disease module extends the Company's mission of promoting early detection and prevention of disease.

"PAD affects eight to 12 million people in the U.S., and represents a significant growth market for hospitals," says Greg Gossett, HealthAware President. "According to the Society of Interventional Radiology, PAD impacts 12 to 20 percent of those over age 65, and nearly 20 percent of all men and women age 70 and older."

Mr. Gossett goes on to say, "Through VascularAware, we will be able to better help hospitals attain their goals, while also helping them to increase their visibility and goodwill within their communities."

PAD is a form of atherosclerosis. The most common type of PAD is the hardening and narrowing of arteries that are caused by the gradual buildup of fatty deposits and additional substances. The result is restricted blood flow, mainly in the arteries that lead to the legs and extremities.

Many people with PAD have no symptoms, which is one reason why it is important to screen for this disease through VascularAware. About one third of those with PAD have symptoms in the form of leg pain, cramping, fatigue or other discomfort in the calves or hips when they are walking or engaged in other activity.

However, these symptoms typically will subside when they rest. Because of this, PAD can often go undiagnosed during its early stages because people mistake their symptoms for a form of arthritis or as simply a sign of aging.

By the time people with PAD begin to suffer from symptoms such as leg discomfort and pain, they may already have severely blocked arteries in their legs and damaged blood vessels in other parts of their body. This can put them at a higher risk for heart attacks and strokes.

When patients utilize VascularAware, the program considers the following risk factors:

-- High blood pressure -- Smoking -- Diabetes

-- High cholesterol -- Family history of -- Over weight

CV disease

-- Over age 50 -- Inactivity/sedentary -- Leg pain

lifestyle

-- TIA symptoms

For more information about VascularAware and HealthAware's mission of promoting early detection and prevention of disease, please contact Cynthia Zeigler, Director, Marketing & PR, at (303) 758-8400, ext. 203.

About HealthAware

HealthAware, a division of Byrne HealthCare, is a respected market leader offering innovative services to healthcare providers that drive more at-risk patients through their door. HealthAware is dedicated to halting the progress of major diseases in the U.S. Our mission is to provide services and systems that save patients, while enabling select healthcare organizations to thrive and grow their market share. The end result being longer, healthier lives for consumers and healthcare organizations that are more vital and productive.


'/>"/>
SOURCE HealthAware
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
2. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
3. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
4. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
5. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
6. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
7. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
8. Finesse Introduces TruBio(TM) IOQ
9. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
10. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2020)... (PRWEB) , ... August 13, 2020 , ... ... its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing ... within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded CDMO ... the purchase of greenfield for a new, expanded manufacturing facility. The site is ... in the initial acquisition, with an option to purchase an additional 21 acres ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... , ... July 29, 2020 , ... eSource has long ... This webinar will cover the history of eSource, the reasons it did not take ... to wearables, to site source, the industry is moving towards capturing data electronically for ...
Breaking Biology Technology:
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
(Date:7/18/2020)... ... July 16, 2020 , ... A ... of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises ... the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other ...
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
Breaking Biology News(10 mins):